US Patent Issued to ABIVAX, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE MONTPELLIER, INSTITUT CURIE on March 11 for "Aryl-n-aryl derivatives for treating a RNA virus infection" (French Inventors)

ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,018, issued on March 11, was assigned to ABIVAX (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), UNIVERSITE DE MONTPELLIER (Montpellier, France) and INSTITUT CURIE (Paris).

"Aryl-n-aryl derivatives for treating a RNA virus infection" was invented by Didier Scherrer (Castelnau-le-Lez, France), Jamal Tazi (Clapiers, France), Florence Mahuteau-Betzer (Saint Remy-les-Chevreuse, France), Romain Najman (L'Hay-les-Roses, France), Julien Santo (Grabels, France) and Cecile Apolit (Grabels, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of formula (Ic) wherein X2 represents a -CO-NRk- group, wherein Rk represents a hydrogen at...